Search Within

Kenneth K Ng

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (7)
Groups
  1. Department of Medicine (17)
  2. Epidemiology and Biostatistics (17)
  3. Solid Tumor Oncology Division (17)
  4. Thoracic Oncology (17)
  5. Biostatistics Service (16)
  6. Weinberg Fellows (12)

More Groups

People
  1. Juliana Eng (11)
  2. Charles Rudin (8)
  3. Daphna Gelblum (8)
  4. Mark Kris (7)
  5. Afsheen Iqbal (6)
  6. Andreas Rimner (6)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (2)
  6. 2016 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)
  2. Clinical Cancer Research (3)
  3. Journal of Clinical Oncology (3)
  4. Annals of Oncology (2)
  5. Nature Medicine (2)
  6. International Journal of Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. Nature Publishing Group (2)
  5. Oxford University Press (2)
  6. Elsevier Ireland Ltd. (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Lebow, E. S.; Fitzgerald, K. J.; Shaverdian, N.; Kotecha, R.; Gomez, D. R.; Wu, A. J.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; Zhang, Z.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Patient-reported experience with an immunotherapy telehealth platform
    Meeting Abstract

    Daly, R. M.; Bange, E. M.; Doshi, S. D.; Li, B. T.; Shah, N. J.; Aggen, D. H.; Kotecha, R. R.; Eng, J.; Ng, K. K.; Polubriaginof, F. C. G.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for stage IIA to IIIA inoperable non-small cell lung cancer: A phase 1 dose-escalation trial
    Journal Article

    Rimner, A.; Gelblum, D. Y.; Wu, A. J.; Shepherd, A. F.; Mueller, B.; Zhang, S.; Cuaron, J.; Shaverdian, N.; Flynn, J.; Fiasconaro, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center
    Journal Article

    Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
    International Journal of Cancer (2021)

    Fulltext@MSK | Save